Report Code : CVMI24072928 | Published Date : July 16, 2024

1 | Market Overview

The European peptide synthesis market includes the production, modification, and commercialization of peptides for pharmaceutical, research, diagnostic, and cosmetic applications. Peptides, which are short chains of amino acids, have gained significant traction in therapeutics due to their high specificity, low toxicity, and ability to target previously undruggable protein interactions.

The region has emerged as a key hub for peptide therapeutics and custom synthesis, supported by robust R&D, a strong CDMO presence, and rising investments in oncology, metabolic, and infectious disease research. Demand is also increasing from the cosmetic and nutritional supplement sectors, where bioactive peptides are used for anti-aging and muscle recovery.

 

2 | Market Size and Forecast

Year

Market Value (USD Million)

Notes

2019

420

Pharma and R&D were leading segments

2024

640

CAGR 8.7% (2019–2024)

2031

1,280

Projected CAGR 10.3% (2024–2031)

 

3 | Drivers & Challenges

Drivers:

  • Rising demand for peptide therapeutics in cancer and metabolic disorders
  • Expansion of contract manufacturing and research services
  • Technological advancements in SPPS, LPPS, and hybrid synthesis
  • Regulatory support for biosimilar and generic peptide drugs

 

Challenges:

  • Complex and costly purification and modification processes
  • Regulatory variability across EU member states
  • Supply chain constraints for rare amino acid reagents

 

4 | Segment Insights

By Product Type:

  • Custom Peptides
  • API-grade Therapeutic Peptides
  • Cosmetic & Nutraceutical Peptides
  • Reagents & Kits for Peptide Synthesis

 

By Technology:

  • Solid Phase Peptide Synthesis (SPPS)
  • Liquid Phase Peptide Synthesis (LPPS)
  • Hybrid & Microwave-Assisted Synthesis

5 | Regional Insights

  • Germany, France & Switzerland (41%) – Pharma R&D and CDMO capacity
  • UK & Ireland (24%) – Biotech innovation and peptide-based therapeutics
  • Italy, Spain & Benelux (20%) – Nutraceutical and dermo-cosmetic peptide demand
  • Nordics & CEE (15%) – Growing CRO and peptide research base

6 | Competitive Landscape

Key players: Bachem AG, Polypeptide Group, CordenPharma, Thermo Fisher Scientific, Merck KGaA, AmbioPharm, BCN Peptides, GenScript, ProteoGenix.

Emerging trends include:

  • Use of AI/ML in peptide drug design
  • Integration of flow chemistry and automation
  • Expansion of peptide payload delivery platforms (e.g., ADCs)




Reasons To Buy

Image



Scope

Image

Key Players

  • Bachem Holding AG
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • GenScript Biotech Corporation
  • CEM Corporation
  • PolyPeptide Group
  • Biotage AB
  • Creative Diagnostics
  • Syngene International Ltd.
  • Puresynth Research Chemicals Pvt Ltd.
  • Lonza
  • CPC Scientific
  • New England Peptide
  • AnaSpec Inc.
  • Biomatik Corporation

 

Peptide Synthesis Market Report

 

  1. 1. Peptide Synthesis Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Peptide Synthesis Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
  2. 2. Peptide Synthesis Market Research Report - Preface
    1. 2.1 Peptide Synthesis Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Product Type:
      2. 2.1.2 By Technology:
      3. 2.1.3 By Region
  3. 3. Peptide Synthesis Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Product Type:, By Technology:, By Country
    3. 3.3. Opportunities – By Product Type:, By Technology:, By Country
    4. 3.4. Trends – By Product Type:, By Technology:, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Peptide Synthesis Market Research Report – DROTs Impact Analysis
    1. 4. Peptide Synthesis Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    2. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    4. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    5. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 5. Peptide Synthesis Market, By Product Type:, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Custom Peptides
    2. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 5.2 API-grade Therapeutic Peptides
    7. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 5.3 Cosmetic & Nutraceutical Peptides
    12. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    16. 5.4 Reagents & Kits for Peptide Synthesis
    17. 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    18. 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    19. 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    20. 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Peptide Synthesis Market, By Technology:, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Solid Phase Peptide Synthesis (SPPS)
    2. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 6.2 Liquid Phase Peptide Synthesis (LPPS)
    7. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 6.3 Hybrid & Microwave-Assisted Synthesis
    12. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 7. Peptide Synthesis Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 Europe
      1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      7.2 Peptide Synthesis Market - Opportunity Analysis Index, By Product Type:, By Technology:, and Region, 2024 - 2031
  1. 8. Europe Peptide Synthesis Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 By Product Type: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.1.1 Custom Peptides
      2. 8.1.2 API-grade Therapeutic Peptides
      3. 8.1.3 Cosmetic & Nutraceutical Peptides
      4. 8.1.4 Reagents & Kits for Peptide Synthesis
      8.2 By Technology: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.2.1 Solid Phase Peptide Synthesis (SPPS)
      2. 8.2.2 Liquid Phase Peptide Synthesis (LPPS)
      3. 8.2.3 Hybrid & Microwave-Assisted Synthesis
      8.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.3.1 Germany
      2. 8.3.2 United Kingdom
      3. 8.3.3 France
      4. 8.3.4 Spain
      5. 8.3.5 Italy
      6. 8.3.6 Russia
    2. 8.4 Europe Peptide Synthesis Market – Opportunity Analysis Index, By Product Type:, By Technology:, and Country, 2024 - 2031
    3. 8.5 Regional Trends Analysis
    4. 8.6 Europe Peptide Synthesis Market Research Report - Company Profiles
      1. 8.6.1 Company 1 (Germany)
      2. 8.6.2 Company 2 (United Kingdom)
      3. 8.6.3 Company 3 (United Kingdom)
    9. Competition Landscape
    1. 9.1 Strategic Dashboard of Top Market Players
    2. 9.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 9.2.1 Bachem Holding AG
      2. 9.2.2 Thermo Fisher Scientific Inc.
      3. 9.2.3 Merck KGaA (Sigma-Aldrich)
      4. 9.2.4 GenScript Biotech Corporation
      5. 9.2.5 CEM Corporation
      6. 9.2.6 PolyPeptide Group
      7. 9.2.7 Biotage AB
      8. 9.2.8 Creative Diagnostics
      9. 9.2.9 Syngene International Ltd.
      10. 9.2.10 Puresynth Research Chemicals Pvt Ltd.
      11. 9.2.11 Lonza
      12. 9.2.12 CPC Scientific
      13. 9.2.13 New England Peptide
      14. 9.2.14 AnaSpec Inc.
      15. 9.2.15 Biomatik Corporation
  1. 10. Data Collection Method and Research Approach
  2. 11. Principal Presumptions and Acronyms